Table 2. Independent predictors of survival following Cox proportional hazards adjustment for patients with stage IIIA-N2 NSCLC who have undergone induction chemotherapy or chemoradiation followed by lobectomy or pneumonectomy.
| Hazard Ratio | 95% CI | p-value | |
|---|---|---|---|
| ICR vs IC | 1.03 | 0.89, 1.18 | 0.73 |
| Lobectomy vs Pneumonectomy | 0.66 | 0.55, 0.79 | <.001 |
| Insurance Type (ref=Private) | |||
| Medicare/aid | 0.99 | 0.84, 1.16 | 0.87 |
| Other government | 1.70 | 1.07, 2.71 | 0.02 |
| Uninsured | 2.15 | 1.44, 3.20 | <.001 |
| Unknown | 1.27 | 0.77, 2.11 | 0.35 |
| Age (year) | 1.02 | 1.01, 1.03 | <.001 |
| Female vs Male | 0.94 | 0.82, 1.08 | 0.37 |
| Race (ref=White) | |||
| Black | 0.92 | 0.70, 1.20 | 0.53 |
| Other | 0.91 | 0.62, 1.34 | 0.64 |
| CDCC Score (ref=0) | |||
| 1 | 1.12 | 0.96, 1.31 | 0.16 |
| 2+ | 1.11 | 0.81, 1.52 | 0.52 |
| Clinical T stage (ref=T1) | |||
| T2 | 1.07 | 0.91, 1.27 | 0.40 |
| T3 | 1.05 | 0.83, 1.33 | 0.68 |
| Facility Type (ref=Academic) | |||
| Community | 1.22 | 0.94, 1.58 | 0.13 |
| Comprehensive | 0.98 | 0.85, 1.13 | 0.76 |
| Histology (ref=Adenocarcinoma) | |||
| Squamous | 0.92 | 0.77, 1.10 | 0.34 |
| Other | 1.01 | 0.87, 1.19 | 0.87 |
| Tumor Location (ref=RUL) | |||
| LLL | 1.43 | 1.12, 1.84 | <.01 |
| LUL | 1.17 | 0.99, 1.39 | 0.08 |
| RLL | 1.45 | 1.18, 1.77 | <.001 |
| RML | 1.09 | 0.71, 1.67 | 0.71 |
| Other | 1.11 | 0.82, 1.50 | 0.50 |